In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Updated Adverse Drug Reaction Reporting Details for Belgium

Updated Adverse Drug Reaction Reporting Details for Belgium

by In2Pharma | Mar 10, 2021 | News

Europe Appendix V of the QRD template has been updated. This appendix lists the details of the national reporting systems for communicating adverse reactions, which must be stated in the SmPC and the package leaflet. In the most recently updated versions of...

Recent Posts

  • Update Procedure for MA applications in Luxembourg
  • Labeling Medicinal products
  • New clarification about Day 0 in local literature search published by EMA
  • Revision IML Code of Ethics
  • CBG starts authorizing temporarily different packaging

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België